American Journal of Neuroradiology 26:1744-1750, August 2005
© 2005 American Society of Neuroradiology
INTERVENTIONAL
Abciximab in Patients with Ruptured Intracranial Aneurysms
a Neuroradiology Section, Imaging Department, Charing Cross Hospital, London, United Kingdom
b Division of Neuroradiology, Department of Radiology, Sunnybrook Hospital, Toronto, Ontario, Canada
Address reprint requests to Dr. Richard Aviv, Division of Neuroradiology, Department of Radiology, Sunnybrook & Womens College Health Sciences Centre, 2075 Bayview Avenue, Toronto ON M4N 3M5
BACKGROUND AND PURPOSE: Experience with intravenous abciximab to manage thromboembolism during treatment of ruptured intracranial aneurysms is limited. We present our experience in 13 patients.
METHODS: We retrospectively reviewed all patients with thromboembolic complications during endovascular management of ruptured intracranial aneurysms. Thromboembolic complications were treated with intravenous abciximab. We recorded patient and aneurysm demographics, aneurysm occlusion, drug therapy, complications, and outcomes.
RESULTS: World Federation of Neurological Surgeons Grades were 1 or 2 in 11 patients (85%). Median time from diagnostic angiography to treatment was 1 day. Ten (77%) aneurysms involved the anterior or posterior communicating artery, and one each occurred in the posterior inferior cerebellar artery, middle cerebral artery, and basilar regions. Eleven aneurysms were <10 mm. Five were incompletely occluded (0%90% treated) at the time of the complication. Thromboembolic complications were at the coil-ball/parent-artery interface in nine patients (69%). Two were associated with coil-loop prolapse; one was prophylactically treated without evidence of thromboembolism. Five patients (38%) had distal complications; one also had a proximal thrombus. All patients received an intravenous bolus of abciximab (510 mg in 92%) without infusion. Postprocedural recanalization was complete in eight (62%) and partial in four (31%). Eleven patients (85%) had a Glasgow Outcome Scale score of 1 at 3 months. One had a poor outcome (GOS4). One died following additional coiling after abciximab administration, though this intervention was uneventful in three others.
CONCLUSION: Abciximab completely or partially treated thromboembolic complications arising during coiling of ruptured aneurysms. Further coiling should be performed with extreme caution and needs to be decided on a patient-by-patient basis.
This article has been cited by other articles:
![]() |
R.A. Willinsky, J. Peltz, L. da Costa, R. Agid, R.I. Farb, and K.G. terBrugge Clinical and Angiographic Follow-up of Ruptured Intracranial Aneurysms Treated with Endovascular Embolization AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 1035 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ries, S. Siemonsen, U. Grzyska, H. Zeumer, and J. Fiehler Abciximab Is a Safe Rescue Therapy in Thromboembolic Events Complicating Cerebral Aneurysm Coil Embolization: Single Center Experience in 42 Cases and Review of the Literature Stroke, May 1, 2009; 40(5): 1750 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.G. Jones, I. Davagnanam, S. Colley, R.J. West, and D.A. Yates Abciximab for Treatment of Thromboembolic Complications during Endovascular Coiling of Intracranial Aneurysms AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1925 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.F. Layton, H.J. Cloft, L.A. Gray, D.A. Lewis, and D.F. Kallmes Balloon-Assisted Coiling of Intracranial Aneurysms: Evaluation of Local Thrombus Formation and Symptomatic Thromboembolic Complications AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1172 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. van Rooij, M. Sluzewski, G.N. Beute, and P.C. Nijssen Procedural Complications of Coiling of Ruptured Intracranial Aneurysms: Incidence and Risk Factors in a Consecutive Series of 681 Patients AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1498 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Blom, M. Korona, L. Haikal, and R. Aviv Platelet Receptors AJNR Am. J. Neuroradiol., January 1, 2006; 27(1): 8 - 9. [Full Text] [PDF] |
||||

